Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPARγ1-3 mRNA expression in human visceral adipocytes

Obesity Surgery

Volumn 21, Issue 3, 2011, Pages 356-361

  Costa, Cíntia Dos Santos ^a   Rohden, Francieli ^a   Hammes, Thais Ortiz ^a   Margis, Rogério ^b   Bortolotto, Josiane Woutheres ^a   Padoin, Alexandre Vontobel ^c   Mottin, Cláudio Cora ^c   Guaragna, Regina Maria ^a  

^a Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adipocytes; Adiponectin; FOXO1; PPAR 1 3; Resveratrol; SIRT1

Indexed keywords

ADIPONECTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 3; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOCYTE; ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MORBID OBESITY; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; UPREGULATION;

EID: 79955781048     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-010-0251-7     Document Type: Article

References (31)

1. Marchesini G, Moscatiello S, Domizio SD et al. Obesityassociated liver disease. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S74-80.
2. Bai L, Pang WJ, Yang, YJ et al. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem. 2008;307(1-2):129-40. (Pubitemid 350238655)
3. Harikumar KB, Aggarwal BB. Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle. 2008;7(8):1020-35.
4. Rivera L, Moron R, Zarzuelo A et al. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol. 2009;77 (6):1053-63.
5. Floyd ZE, Wang ZQ, Kilroy G et al. Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol. Metabolism. 2008;57(7 Suppl 1):S32-8. (Pubitemid 351814704)
6. Baur JA, Pearson KJ, Price NL et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444 (7117):337-42. (Pubitemid 44764104)
7. Lagouge M, Argmann C, Gerhart-Hines Z et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell. 2006;127 (6):1109-22. (Pubitemid 44894520)
8. Picard F, Kurtev M, Chung N et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 2004;429(6993):771-6. (Pubitemid 38833129)
9. Howitz KT, Bitterman KJ, Cohen HY et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191-6. (Pubitemid 37150899)
10. Wang F, Tong Q. SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. Mol Biol Cell. 2009;20(3):801-8.
11. Subauste AR, Burant CF. Role of FoxO1 in FFA-induced oxidative stress in adipocytes. Am J Physiol Endocrinol Metab. 2007;293(1):E159-64. (Pubitemid 47105929)
12. Ma H, Gomez V, Lu L et al. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2009;24(2):233-7.
13. Rogers CQ, Ajmo JM, You M. Adiponectin and alcoholic fatty liver disease. IUBMB Life. 2008;60(12):790-7.
14. Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res. 2005;51(2):85-94. (Pubitemid 40040538)
15. Semple RK, Chatterjee VK, O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest. 2006;116(3):581-9. (Pubitemid 43326862)
16. Mitsuishi M, Miyashita K, Itoh H. Metabolic syndrome. Nippon Rinsho. 2009;67(2):321-6.
17. Rodbell M. Metabolism of isolated fat cells: I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 1964;239:375-80.
18. Rieusset J, Andreelli F, Auboeuf D et al. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes. 1999;48(4):699-705. (Pubitemid 29153067)
19. Walle T, Hsieh F, DeLegge MH et al. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32(12):1377-82. (Pubitemid 39564557)
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402-8. (Pubitemid 34164012)
21. Shan T, Wang Y, Wu T et al. Porcine sirtuin 1 gene clone, expression pattern, and regulation by resveratrol. J Anim Sci. 2009;87(3):895-904.
22. Alcain FJ, Villalba JM. Sirtuin activators. Expert Opin Ther Pat. 2009;19(4):403-14.
23. Costa CS, Hammes TO, Rohden F et al. SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. Obes Surg. 2009.
24. Nisoli E, Clementi E, Carruba MO et al. Defective mitochondrial biogenesis: A hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res. 2007;100(6):795-806. (Pubitemid 46555684)
25. Gross DN, van den Heuvel AP, Birnbaum MJ. The role of FoxO in the regulation of metabolism. Oncogene. 2008;27(16):2320-36. (Pubitemid 351501783)
26. Pillarisetti S. A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent Pat Cardiovasc Drug Discov. 2008;3(3):156-64.
27. Qiao L, Shao J. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem. 2006;281(52):39915-24. (Pubitemid 46041795)
28. Wang YX, Lee CH, Tiep S et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 2003;113(2):159-70. (Pubitemid 36514968)
29. Bortolotto JW, Margis R, Ferreira ACB et al. Adipose tissue distribution and quantification of PPARβ/δ and PPARgamma1- 3 mRNAs: Discordant gene expression in subcutaneous, retroperitoneal and visceral adipose tissue of morbidly obese patients. Obes Surg. 2007;17(7):934-40. (Pubitemid 350042922)
30. Rayalam S, Yang JY, Ambati S et al. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res. 2008;22(10):1367-71.
31. Pang WJ, Sun SD, Bai L et al. Effects of resveratrol on pig primary preadipocytes proliferation, differentiation and transcription expression of Sirt1 gene. Sheng Wu Gong Cheng Xue Bao. 2006;22(5):850-5.